Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications
about
Pharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide?Recent advances in treatment of heart failureSelective Regulation of Oocyte Meiotic Events Enhances Progress in Fertility Preservation MethodsCardiovascular-renal axis disorders in the domestic dog and cat: a veterinary consensus statementRegulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucomaKnockdown of Carboxypeptidase A6 in Zebrafish Larvae Reduces Response to Seizure-Inducing Drugs and Causes Changes in the Level of mRNAs Encoding Signaling MoleculesNatriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptideMendelian randomization study of B-type natriuretic peptide and type 2 diabetes: evidence of causal association from population studiesPrevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice.A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions.Natriuretic peptides improve the developmental competence of in vitro cultured porcine oocytes.Characterization and functional expression of the natriuretic peptide system in human lens epithelial cellsGuanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte.In vitro and in vivo pharmacological profile of PL-3994, a novel cyclic peptide (Hept-cyclo(Cys-His-Phe-d-Ala-Gly-Arg-d-Nle-Asp-Arg-Ile-Ser-Cys)-Tyr-[Arg mimetic]-NH(2)) natriuretic peptide receptor-A agonist that is resistant to neutral endopeptidaAC-NP: a novel chimeric peptide with natriuretic and vasorelaxing actions.Endogenous vascular synthesis of B-type and C-type natriuretic peptides in the rainbow trout.Influence of gestational overfeeding on cardiac morphometry and hypertrophic protein markers in fetal sheepEndothelial C-type natriuretic peptide maintains vascular homeostasis.Arg13 of B-type natriuretic Peptide reciprocally modulates binding to guanylyl cyclase but not clearance receptors.Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications.cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.Circulating N-terminal pro-B-type natriuretic peptide in fetal anemia before and after treatment.A functional screen provides evidence for a conserved, regulatory, juxtamembrane phosphorylation site in guanylyl cyclase a and B.C-type natriuretic peptide slows down wound healing but promotes angiogenesis in SKH1-hr hairless mice.The three integrated phases of left atrial macrophysiology and their interactions.Cocaine-associated increase of atrial natriuretic peptides: an early predictor of cardiac complications in cocaine users?Inhibitory effects of C-type natriuretic peptide on the differentiation of cardiac fibroblasts, and secretion of monocyte chemoattractant protein-1 and plasminogen activator inhibitor-1.Insulin-degrading enzyme modulates the natriuretic peptide-mediated signaling response.Regulation of hippocampal synaptic plasticity thresholds and changes in exploratory and learning behavior in dominant negative NPR-B mutant rats.Cardiorenal syndrome is present in human fetuses with severe, isolated urinary tract malformationsSex differences in the beneficial cardiac effects of chronic treatment with atrial natriuretic Peptide in spontaneously hypertensive rats.B-type natriuretic peptide-induced delayed modulation of TRPV1 and P2X3 receptors of mouse trigeminal sensory neurons.Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi.Plasma C-type natriuretic peptide as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndromeThe indolocarbazole, Gö6976, inhibits guanylyl cyclase-A and -B.Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction.Activation of natriuretic peptides and the sympathetic nervous system following Roux-en-Y gastric bypass is associated with gonadal adipose tissues browning.Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study.A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertensionNatriuretic peptide metabolism, clearance and degradation.
P2860
Q26765883-F0246BBF-B899-49D9-AC84-95B6DD181B70Q26766223-143E2CAC-0D1F-43E1-A1C7-847511D1E4F6Q26784715-49CF2002-7E8B-4983-BBF7-F121C0FF66C4Q26786569-984962D4-FF68-4B2A-9985-DCBC61B5C637Q26861763-0FA3A0F5-0E65-470D-B33D-466D9C606597Q27315088-949BC73E-DE1E-4CB4-A1CB-6F4A8EB0AA55Q28570682-11FD13C6-156C-4A17-9A00-2D4013786EFEQ28743489-859E51B7-153F-4F33-8C10-613502F433E4Q30626615-29663680-2A59-4760-A517-335F25AA6E1FQ33577067-C95D7E2E-D2B3-4D6D-B94D-AFED4C2F375DQ33742836-47681B0B-1521-4568-9E94-6E0F19C9254FQ33781337-9A15572C-FAFF-49E6-9E57-C5AF883933C0Q33792340-77317769-1AD9-45D5-9F7B-28D1662D8584Q33804636-FC8BE3A9-FB08-4AC6-B41B-7EE8C7ADC21AQ33925169-57EC228D-752F-465D-9441-846BE3F70C74Q33973358-E02FF1E2-1217-4CF0-8346-6E1C1441046AQ33983596-755D83A0-E4AA-46A8-A981-4BB9BEC1463DQ34117544-9113066D-60A2-4402-8F01-8B9ED74B2E34Q34127995-A3ECD003-AACB-420C-8BAE-57BC9D6C3BB2Q34150487-37AA3AEB-4B3C-4B10-B26D-115B94E8F148Q34244951-DB3873FE-E2BC-4B8C-8319-F135AEF3CFA6Q34252233-C376F665-81F5-4266-A05A-973CA9A410D3Q34270975-E6540143-BB01-4666-9BED-A6747CD77BD6Q34304206-978DA1B0-AB5F-43DA-8BCC-642F8EB3C7C2Q34358906-FF4384DE-0485-44E1-A8D6-E63ACB0694E8Q34531512-FC733217-0F57-424F-851E-1C2C9A6D89CBQ34540845-1B47F805-C8E1-416F-B96B-3D5F3625F0F8Q34575644-95D7BFE8-E6D4-4277-A25B-039C87E08202Q34597060-E01BCC9A-0824-4F1D-9E79-0B5003B9B360Q34744358-7C97F207-B85F-437F-8D56-559B2018D23EQ34951017-4E1CE69F-34FF-46DC-A699-1CAA22190D6EQ35060436-393F1AE7-B374-4A55-9D03-00987A0A79BBQ35195548-B81D337D-5BBA-44BF-A640-702DFEFD3EFAQ35219788-2FCC449B-E8FC-4AC4-AAED-118D52D94B95Q35287220-B72A82AC-8BCA-485D-8017-2A117EB5D0DBQ35407690-5E8D3F0B-C94D-453C-9F54-E88D9BAA3E78Q35573512-D5DFA694-9CCA-4AD2-B72F-E5A65347992FQ35586340-D482D564-B582-4492-8964-0025939968A4Q35659994-E8041AE7-D411-4F35-B35B-1FCAA57CB404Q35831469-B0EEC4CB-0E49-450E-8A93-31EA62147B79
P2860
Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Natriuretic peptides: their st ...... s and therapeutic applications
@ast
Natriuretic peptides: their st ...... s and therapeutic applications
@en
Natriuretic peptides: their st ...... s and therapeutic applications
@nl
type
label
Natriuretic peptides: their st ...... s and therapeutic applications
@ast
Natriuretic peptides: their st ...... s and therapeutic applications
@en
Natriuretic peptides: their st ...... s and therapeutic applications
@nl
prefLabel
Natriuretic peptides: their st ...... s and therapeutic applications
@ast
Natriuretic peptides: their st ...... s and therapeutic applications
@en
Natriuretic peptides: their st ...... s and therapeutic applications
@nl
P2093
P2860
P1476
Natriuretic peptides: their st ...... s and therapeutic applications
@en
P2093
Andrea R Yoder
Darcy R Flora
Deborah M Dickey
Laura K Antos
Lincoln R Potter
P2860
P304
P356
10.1007/978-3-540-68964-5_15
P577
2009-01-01T00:00:00Z